Open AccessThe role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer
Author(s) -
Hongbing Liu,
Xiaoling Gu,
Tangfeng Lv,
Ying Wu,
Yao Xiao,
Dongmei Yuan,
Yufeng Li,
Yong Song
Publication year - 2014
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.136541
Subject(s) - carcinoembryonic antigen , medicine , chemotherapy , oncology , lung cancer , receiver operating characteristic , retrospective cohort study , gastroenterology , medical record , cancer
Previous studies indicated that carcinoembryonic antigen (CEA) could predict the therapeutic objective response (OR) and overall survival (OS) of patients with cancers, including non-small cell lung cancer (NSCLC). However, the role it could play in evaluating therapeutic responses and OS in patients with NSCLC requires further elucidation. Herein, we investigated the potential role of CEA in predicting OR and OS in patients with NSCLC.